IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes

Diabetes Care

Volumn 27, Issue 11, 2004, Pages 2695-2700

  Bonifacio, Ezio ^a,b   Hummel, Michael ^b   Walter, Markus ^b   Schmid, Sandra ^b   Ziegler, Anette G ^b,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Klinikum Schwabing   (Germany)

^c INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; PANCREAS ISLET CELL ANTIBODY;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHILD; FAMILY HISTORY; FOLLOW UP; GENETIC MARKER; GENOTYPE; HIGH RISK POPULATION; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LIFE TABLE; NEWBORN PERIOD; ORAL GLUCOSE TOLERANCE TEST; PROSPECTIVE STUDY; STATISTICAL ANALYSIS;

AGING; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT, NEWBORN; MEDICAL RECORDS; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS;

EID: 7444253875     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.11.2695     Document Type: Article

References (24)

1. Eisenbarth GS: Type 1 diabetes mellitus: a chronic autoimmune disease. N Engl J Med 314:1360-1368, 1986
2. Aktinson MA, MacLaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428-1436, 1994
3. Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229, 2001
4. Diabetes Prevention Trial-Type 1 Diabetes Study Group: Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346:685-689, 2002
5. Gale EA, Bingley PJ, Emmett CL, Collier T, European Nicotinamide Diabetes Intervention Trial (ENDIT) Group: European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363:925-931, 2004
6. Ziegler AG, Hummel M, Schenker M, Bonifacio E: Autoantibody appearance and risk for the development of childhood diabetes in offspring of parents with type 1 diabetes: the German BABY-DIAB Study. Diabetes 48:460-468, 1999
7. Walter M, Albert E, Conrad M, Keller E, Hummel M, Ferber K, Barratt BJ, Todd J, Ziegler AG, Bonifacio E: IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia 46:712-720, 2003
8. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E: Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 290:1721-1728, 2003
9. Naserke HE, Bonifacio E, Ziegler AG: Immunoglobulin G insulin autoantibodies in BABYDIAB offspring appear postnatally: sensitive early detection using a protein A/G-based radiobinding assay. J Clin Endocrinol Metab 84:1239-1243, 1999
10. Kimura A, Sasazuki T: 11th International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In HLA. Vol. 1. Tsuji K, Aizawa A, Sasazuki T, Eds. Oxford, U.K., Oxford University Press, 1992, p. 397-419
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
12. EURODIAB ACE Study Group: Variation and trends in incidence of childhood diabetes in Europe. Lancet 355:873-876, 2000
13. Karvonen M, Pitkaniemi J, Tuomilehto J: The onset age of type 1 diabetes in Finnish children has become younger. Diabetes Care 22:1066-1070, 1999
14. Gale EA: The rise of childhood type 1 diabetes in the 20th century. Diabetes 51:3353-3361, 2002
15. Norris JM, Barriga K, Klingensmith G, Huffman M, Eisenbarth GS, Erlich HA, Rewers M: Timing of initial cereal exposure in infancy affects risk of islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY). JAMA 290:1713-1720, 2003
16. Honeyman MC, Coulson BS, Stone NL, Geliert SA, Goldwater PN, Steele CE, Couper JJ, Tait BD, Colman PG, Harrison LC: Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49:1319-1324, 2000
17. El Hashimy M, Angelico MC, Martin BC, Krolewski AS, Warram JH: Factors modifying the risk of IDDM in offspring of an IDDM parent. Diabetes 44:295-299, 1995
18. Warram JH, Krolewski AS, Gottlieb MS, Kahn CR: Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 311:149-152, 1984
19. Eurodiab Ace Study Group, Eurodiab Ace Substudy 2 Study Group: Familial risk of type 1 diabetes in European children. Diabetologia 41:1151-1156, 1998
20. Lorenzen T, Pociot F, Stilgren L, Kristiansen OP, Johannesen J, Olsen PB, Walmar A, Larsen A, Albrechtsen NC, Eskildsen PC, Andersen OO, Nerup J: Predictors of IDDM recurrence risk in offspring of Danish IDDM patients: Danish IDDM Epidemiology and Genetics Group. Diabetologia 41:666-673, 1998
21. Tuomilehto J, Podar T, Tuomilehto-Wolf E, Virtala E: Evidence for importance of gender and birth cohort for risk of IDDM in offspring of IDDM parents. Diabetologia 38:975-982, 1995
22. Colman PG, Steele C, Couper JJ, Beresford SJ, Powell T, Kewming K, Pollard A, Gellen S, Tait B, Honeyman M, Harrison LC: Islet autoimmunity in infants with a type 1 diabetic relative is common but is frequently restricted to one autoantibody. Diabetologia 43:203-209, 2000
23. Hamalainen AM, Ronkainen MS, Akerblom HK, Knip M: Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes: the Finnish TRIGR Study Group trial to reduce IDDM in the genetically at risk. J Clin Endocrinol Metab 85:4249-4253, 2000
24. Atkinson M, Gale EAM: Infant diets and type 1 diabetes: too early, too late, or just too complicated? (Editorial). JAMA 290:1771-1772, 2003